Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Pummer

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Histopathology|June 28, 2013
Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinomaGeorg C Hutterer, Martin Pichler, Thomas F Chromecki, et al.
Histopathology|October 2, 2012
Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
International Journal of Molecular Sciences|April 20, 2016
Current Insights into Long Non-Coding RNAs in Renal Cell CarcinomaMaximilian Seles, Georg C Hutterer, Tobias Kiesslich, et al.
The Journal of Urology|February 12, 2014
Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinomaMartin Pichler, Orietta Dalpiaz, Georg C Ehrlich, et al.
Journal of Clinical Pathology|February 10, 2015
Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinomaGeorg C Hutterer, N Sobolev, Georg C Ehrlich, et al.
BJU International|September 24, 2011
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsyMarco Auprich, Herbert Augustin, Lars Budäus, et al.
Journal of Clinical Pathology|April 12, 2015
Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinomaOrietta Dalpiaz, Martin Pichler, Edvin Mrsic, et al.
BJU International|September 24, 2013
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaOrietta Dalpiaz, Georg C Ehrlich, Sebastian Mannweiler, et al.
World Journal of Urology|February 11, 2014
Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional studyAnton Ponholzer, Sophina Trubel, Paul Schramek, et al.
Central European Journal of Urology|April 24, 2019
Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinomaJohannes Mischinger, Eleonore Fröhlich, Sebastian Mannweiler, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Histopathology|June 28, 2013
Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinomaGeorg C Hutterer, Martin Pichler, Thomas F Chromecki, et al.
Histopathology|October 2, 2012
Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
International Journal of Molecular Sciences|April 20, 2016
Current Insights into Long Non-Coding RNAs in Renal Cell CarcinomaMaximilian Seles, Georg C Hutterer, Tobias Kiesslich, et al.
The Journal of Urology|February 12, 2014
Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinomaMartin Pichler, Orietta Dalpiaz, Georg C Ehrlich, et al.
Journal of Clinical Pathology|February 10, 2015
Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinomaGeorg C Hutterer, N Sobolev, Georg C Ehrlich, et al.
BJU International|September 24, 2011
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsyMarco Auprich, Herbert Augustin, Lars Budäus, et al.
Journal of Clinical Pathology|April 12, 2015
Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinomaOrietta Dalpiaz, Martin Pichler, Edvin Mrsic, et al.
BJU International|September 24, 2013
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaOrietta Dalpiaz, Georg C Ehrlich, Sebastian Mannweiler, et al.
World Journal of Urology|February 11, 2014
Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional studyAnton Ponholzer, Sophina Trubel, Paul Schramek, et al.
Central European Journal of Urology|April 24, 2019
Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinomaJohannes Mischinger, Eleonore Fröhlich, Sebastian Mannweiler, et al.
Pageof 11